{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:30:23Z","timestamp":1791261023904,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2011,1,1]]},"DOI":"10.2174\/187152011794941145","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T15:35:50Z","timestamp":1337873750000},"page":"99-108","source":"Crossref","is-referenced-by-count":35,"title":["PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis"],"prefix":"10.2174","volume":"11","author":[{"given":"Katarzyna","family":"Guzinska-Ustymowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pryczynicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/73437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:34:27Z","timestamp":1448289267000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-5206&volume=11&issue=1&spage=99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/187152011794941145","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,1]]}}}